Literature DB >> 2898153

Epithelial dysfunction and airway hyperreactivity in asthma.

R G Goldie1, L B Fernandes, P J Rigby, J W Paterson.   

Abstract

It is clear that the central airway epithelium plays an important role in restricting access of inhaled solutes to sub-epithelial airway wall structures. Non-specific airway hyperreactivity to spasmogens in asthma may result partly as a consequence of the compromise of the epithelium as a barrier to solute diffusion. However, impaired epithelial production and release of smooth muscle relaxant factor(s) may also contribute to airway hyperresponsiveness. Virally precipitated asthma also involves inflammation-induced epithelial damage. Beta-adrenoceptor hypofunction induced by respiratory viruses may also contribute to bronchial obstruction.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2898153

Source DB:  PubMed          Journal:  Prog Clin Biol Res        ISSN: 0361-7742


  4 in total

Review 1.  The barrier hypothesis and Oncostatin M: Restoration of epithelial barrier function as a novel therapeutic strategy for the treatment of type 2 inflammatory disease.

Authors:  Kathryn L Pothoven; Robert P Schleimer
Journal:  Tissue Barriers       Date:  2017-06-13

2.  The effects of epithelium removal on the actions of cholinomimetic drugs in opened segments and perfused tubular preparations of guinea-pig trachea.

Authors:  R C Small; D M Good; J S Dixon; I Kennedy
Journal:  Br J Pharmacol       Date:  1990-07       Impact factor: 8.739

3.  Analysis of the relaxant effects of AH 21-132 in guinea-pig isolated trachealis.

Authors:  R C Small; J P Boyle; S Duty; K R Elliott; R W Foster; A J Watt
Journal:  Br J Pharmacol       Date:  1989-08       Impact factor: 8.739

4.  Modulation by the epithelium of the extent of bronchial narrowing produced by substances perfused through the lumen.

Authors:  M P Sparrow; H W Mitchell
Journal:  Br J Pharmacol       Date:  1991-05       Impact factor: 8.739

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.